Seiji Yoshizawa

Fukuoka, JP 
Fukuoka, JP 

Overview

Seiji Yoshizawa practices practicing medicine in Fukuoka, Japan.

His clinical expertise encompasses Rheumatoid Arthritis (RA), Rheumatoid Vasculitis, Arthritis, and Vasculitis.

He is actively involved in clinical research, co-authoring 27 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Fukuoka, Japan
Other Locations
Japan
Chuo, 8108539, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: November 23, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 1 Less Clinical Trial

27 Total Publications

Joint involvement patterns and patient-reported satisfaction in difficult-to-treat rheumatoid arthritis: results from the multicentre observational cohort, FRANK Registry.
Joint involvement patterns and patient-reported satisfaction in difficult-to-treat rheumatoid arthritis: results from the multicentre observational cohort, FRANK Registry.
Journal: Modern rheumatology
Published: August 04, 2025

Frequently Asked Questions about Seiji Yoshizawa

Is Seiji Yoshizawa a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Seiji Yoshizawa is classified as an Experienced expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Seiji Yoshizawa participate in research or clinical trials?

Yes. Seiji Yoshizawa has published 27 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Seiji Yoshizawa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Yoshizawa's expertise for a condition
ConditionClose
        View All 13 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile